KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Acquisitions & Divestments (2016 - 2025)

Pacira BioSciences (PCRX) has 15 years of Change in Acquisitions & Divestments data on record, last reported at $47.1 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments changed 0.42% year-over-year to $47.1 million; the TTM value through Dec 2025 reached $273.8 million, up 52.48%, while the annual FY2025 figure was $273.8 million, 52.48% up from the prior year.
  • Change in Acquisitions & Divestments reached $47.1 million in Q4 2025 per PCRX's latest filing, down from $86.2 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $598.1 million in Q4 2021 and bottomed at $33.5 million in Q2 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $105.1 million, with a median of $69.2 million recorded in 2025.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 290.67% in 2021, then tumbled 85.8% in 2022.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $598.1 million in 2021, then crashed by 85.8% to $84.9 million in 2022, then tumbled by 57.5% to $36.1 million in 2023, then skyrocketed by 30.05% to $46.9 million in 2024, then grew by 0.42% to $47.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $47.1 million in Q4 2025, $86.2 million in Q3 2025, and $71.2 million in Q2 2025.